trending Market Intelligence /marketintelligence/en/news-insights/trending/omfatf3fei2ssnjmd23ujq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Petlife Pharmaceuticals CEO resigns; replacement named

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Petlife Pharmaceuticals CEO resigns; replacement named

Petlife Pharmaceuticals Inc. appointed Laura De Leon Castro as president, CEO, secretary, treasurer, CFO and board chairman after the resignation of Ralph Salvagno, effective March 22.

Salvagno's resignation was not the result of any disagreements with the company regarding its operations, policies, practices or otherwise, according to the company.

Castro has previously served as the assistant to the CEO of Gatorade Mexico from 2001 to 2003.

In addition, Vyvyan Campbell resigned as director of Petlife Pharmaceuticals, also effective March 22.

Petlife said Campbell's resignation was not the result of any disagreements with the company regarding operations, policies, practices or otherwise.

Hancock, Md.-based Petlife Pharmaceuticals engages in the research, development, sale, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases in the U.S.